Ryner Lai, MBBS

All articles by Ryner Lai, MBBS

• When to seek a second opinion after a systemic mastocytosis diagnosis

  The risk of a misdiagnosis in SM is low.

• Patients with SM and multiple cancers have reduced overall survival

  Multiple cancers is a risk factor for a poorer prognosis in SM.

• Subtypes explained: What is indolent systemic mastocytosis?

  Indolent SM accounts for 90% of SM cases.

• Case report: Diagnosis of indolent SM in the absence of classic symptoms

  Indolent SM may be diagnosed despite the absence of classic symptoms associated with this disorder.

• Subtypes explained: What is aggressive systemic mastocytosis?

  In aggressive SM, cancer cells may proliferate at a considerable pace.

• Subtypes explained: What is smoldering systemic mastocytosis?

  Smoldering SM is a slowly progressive subtype of SM.

• What is a stem cell transplant for systemic mastocytosis?

  Stem cell transplants carry the risk of potentially fatal complications, and are only used when other treatments have been exhausted.

• New research characterizes bone marrow mast cells in systemic mastocytosis

  Scientists observed differences in bone marrow mast cell characteristics across different mast cell disorders.

• Study highlights potential connections between cold-induced anaphylaxis and SM

  Research shows a possible link between cold urticaria and cold-induced anaphylaxis with systemic mastocytosis.

• Why is SM considered a type of cancer? 

  SM is considered a cancer because of the abnormal buildup of mast cells that occurs with the disease.